Loading…
Loading…
RDI does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for RDI and 80,000+ other tickers.
See exactly how RDI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RDI and 80,000+ other tickers.
Reading International, Inc. (RDI) is an enterprise primarily involved in the ownership, expansion, and management of both entertainment venues and property holdings across the United States, Australia, and New Zealand. The company operates through two main divisions: Cinema Exhibition and Real Estate. Its Cinema Exhibition segment oversees numerous multiplex movie theaters, operating under banners such as Reading Cinemas, Angelika Film Center, Consolidated Theatres, State Cinema, Event Cinemas, and Rialto Cinemas. The Real Estate division focuses on developing, leasing, or licensing various…
Reading International, Inc. (RDI) Q2 2026 Earnings Call Transcript
Earnings Call Webcast to Discuss Second Quarter Financial Results Scheduled to Post to Corporate Website on Tuesday, August 18, 2026
Reading International, Inc. (RDI) Q1 2026 Earnings Call Transcript
Earnings Call Webcast to Discuss First Quarter Financial Results Scheduled to Post to Corporate Website on Tuesday, May 19, 2026 NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Reading International, Inc. (NASDAQ: RDI) (“Reading” or our “Company”), an internationally diversified cinema and real estate company with operations and assets in the United States, Australia, and New Zealand, today announced its results for the First Quarter ended March 31, 2026. Key Financial Summary Results –First Quarter 2026 Total Revenues of $45.1 million increased by 12% from $40.2 million in Q1 2025.
Company also announces Marketing Engagement VANCOUVER, BC / ACCESS Newswire / April 7, 2026 / Onco-Innovations Limited (CBOECA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H) (WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the execution of an engagement agreement with Research & Development Incentives Partners ("RDI Partners"), and the formation of Onco-Innovations AU Pty. Ltd. ("ONCO AU") as a wholly owned Australian subsidiary of the Company.